StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > What would happen

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Dec 20, 2022 2:57pm

99 Views

Post# 35182891

RE:What would happen

GEM needs to sell 4 million shares at 0.005 to 0.01 to make a whopping $40,000. Why would they drop it and sell at 0.06, the same price they paid? More money to be made at selling into the run. They will wait until a news announcement and dump into the run. So we wait.......and get to watch you and your buddy Tripin spew the same mess all day long.